| Filed On | Filing |
|---|---|
| 07 Oct 2026 | DEFA14A |
| 05 Oct 2026 | DEFA14A |
| 05 Oct 2026 |
Proxy statement: annual meeting on November 18, 2026
say-on-pay vote |
| 05 Oct 2026 | ARS |
| 25 Sep 2026 | 8-K: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 |
| 25 Sep 2026 | PRE 14A |
| 16 Sep 2026 | D |
| 08 Sep 2026 |
Form 4: Rose Matthew K, Director and 1 other
Bought 1,913,889 shares · Acquired 1,913,889 Common Stock Warrants (right to buy) (Open Market Purchase) |
| 04 Sep 2026 | 8-K: Other Events |
| 03 Sep 2026 | SCHEDULE 13D/A |
| 03 Sep 2026 |
Form 4: Nichol Gareth, 10% owner
Bought 2,000,000 shares · Acquired 2,000,000 Warrant (right to buy) (Open Market Purchase) |
| 03 Sep 2026 | SCHEDULE 13D |
| 02 Sep 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 18 Aug 2026 | 8-K: Other Events |
| 18 Aug 2026 | 10-Q |
| 17 Aug 2026 | 8-K: Other Events |
| 14 Aug 2026 | NT 10-Q |
| 10 Aug 2026 | 8-K: Financial Statements and Exhibits |
| 18 May 2026 | 8-K: Other Events |
| 15 May 2026 | 10-Q |
Loading...
